# Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074

> **NCT02228733** · PHASE1 · COMPLETED · sponsor: **KBP Biosciences** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** KBP-5074

## Key facts

- **NCT ID:** NCT02228733
- **Lead sponsor:** KBP Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02228733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02228733, "Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02228733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*